Catheter Precision, Inc. (VTAK): Unregistered Sales of Equity Securities
Catheter Precision, Inc. (VTAK) filed an SEC Form 8-K — Unregistered Sales of Equity Securities. EX-3.1 2 ex_993841.htm EXHIBIT 3.1 ex_993841.htm Exhibit 3.1 CATHETER PRECISION, INC. CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS OF SERIES C-4 CONVERTIBLE PREFERRED STOCK The undersigned, Philip Anderson, does hereby certify that: 1. I am the Chief Financia
How this was made
The 30-second read
Why it matters
This can change dilution expectations and near-term risk pricing, especially for thinly traded small caps. Without the issuance size and terms, the main actionable takeaway is that a new equity transaction occurred and may be followed by further filings (e.g., registration rights, conversion updates).
Market read
A fresh SEC filing confirms an equity issuance event occurred today, which can drive trading around dilution and financing risk.
What to watch
Traders should look for the missing details in the full 8-K exhibits: share count, consideration received, conversion terms, and whether the issuance is tied to existing investors or new capital providers.
Background
The SEC 8-K Item 3.02 disclosure is used to report unregistered sales of equity securities, typically under Securities Act exemptions.
Ticker impact
Catheter Precision filed an 8-K for Item 3.02, unregistered sales of equity securities, indicating a new capital-raising/issuance event.
Short-term volatility is possible, with direction depending on deal size, pricing, and whether proceeds fund operations.
Item 3.02 is a primary regulatory disclosure of unregistered equity sales; the excerpt does not provide the number of shares, pricing, or proceeds, limiting precision on dilution magnitude.
Market effects
Microcap/small-cap issuers may see investor scrutiny around exemption-based financings and dilution risk.
Primarily affects US-listed small-cap sentiment.
Limited, company-specific regulatory disclosure.
Counterpoint
If the unregistered issuance is small or tied to conversion mechanics with limited incremental dilution, the market impact may be muted.
Key entities
- issuerCatheter Precision, Inc.
US-listed company disclosing unregistered sales of equity securities via SEC Form 8-K Item 3.02.
- securitySeries C-4 Convertible Preferred Stock
Exhibit text references a certificate of designation for convertible preferred, relevant to potential conversion/dilution mechanics.
